首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Antiobesity Effects of the Combined Plant Extracts Varying the Combination Ratio of Phyllostachys pubescens Leaf Extract and Scutellaria baicalensis Root Extract
【24h】

Antiobesity Effects of the Combined Plant Extracts Varying the Combination Ratio of Phyllostachys pubescens Leaf Extract and Scutellaria baicalensis Root Extract

机译:组合植物提取物的抗菌作用改变了Phyllostachys Pubescens Lead提取物和Scutellaria Baicalensis根提取物的组合比

获取原文
获取原文并翻译 | 示例
           

摘要

The antiobesity effects of several different combinations of extracts (BS) prepared from two plants, Phyllostachys pubescens leaf (bamboo leaf: BL) and Scutellaria baicalensis root (SB), were investigated using a high fat diet (HFD) induced obese mouse model. In order to find the most effective mixture among the mixtures of the two plant extracts, experimental preparations were made by combining BL and SB by different proportions of 3 : 1 (BS31), 2 : 1 (BS21), 1 : 1 (BS11), 1 : 2 (BS12), and 1 : 3 (BS13). Body weight, weight of adipose tissues, size of adipocytes, levels of glucose, leptin and adiponectin, and lipid profile in serum, and fat accumulation in liver were investigated. We have found that BS21 is the most effective in antiobesity among the five mixtures investigated, indicated by reduction in body weight gain, total mass of adipose tissue, and the size of adipocyte. In addition, BS21 has shown to be beneficial in serum lipid profile, levels of glucose, leptin, and adiponectin in serum, and fat accumulation in liver. By chromatographic separation of BS21, the two maker compounds, isoorientin and baicalin, were identified and quantified for the standardization of BS21.
机译:使用高脂饮食(HFD)诱导的肥胖小鼠模型研究了由两种植物,Phyllostachys Pubescens叶(竹叶:BL)和Scutellaria baicalensis根(Sb)进行了几种不同组合的提取物(BS)的抗病效应。为了发现两种植物提取物的混合物中最有效的混合物,通过将BL和Sb与3:1(BS31),2:1(BS21),1:1(BS11)相结合的不同比例来制备实验制剂,1:2(bs12)和1:3(bs13)。研究体重,脂肪组织的体重,脂肪细胞的大小,葡萄糖,瘦素和脂肪切除蛋白,以及血清中的脂质曲线以及肝脏的脂肪曲线。我们发现BS21是研究的五种混合物中最有效的抗菌性,通过减少体重增加,脂肪组织的总质量和脂肪细胞的大小表示。此外,BS21显示在血清中血清脂质曲线,葡萄糖,瘦素和脂肪蛋白水平的有益,以及肝脏脂肪积累。通过BS21的色谱分离,鉴定了两种制造商化合物,胰岛素和黄芩苷,用于BS21的标准化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号